🎈 Up Big Today: Find today's biggest gainers (some over 50%!) with our free screenerTry Stock Screener

UPDATE 2-Travel rebound, Adidas support European stocks despite mixed data

Published 23/09/2020, 10:00
© Reuters.
UK100
-
FCHI
-
DE40
-
STOXX50
-
ADSGN
-
LHAG
-
BBVA
-
GMAB
-
ICAG
-
STOXX
-
OSRn
-
AMS
-
SXTP
-
PUMG
-

(For a live blog on European stocks, type LIVE/ in an Eikon
news window)
* Adidas, Puma surge after Nike's upbeat forecast
* Travel stocks rebound after 4-day losing streak
* Sunak to set out future of UK job support programme

(Updates to market close)
By Sruthi Shankar
Sept 23 (Reuters) - European stocks rose on Wednesday, as a
rebound in beaten-down travel stocks and gains for Adidas and
other sports names took the edge off data that highlighted an
uneven path for economic recovery in the euro zone.
With COVID-19 cases rising again in Europe, countries
including Britain reimposed restrictions to limit the spread of
the virus, triggering the worst selloff in three months for the
pan-European STOXX 600 .STOXX benchmark on Monday.
The index closed 0.6% higher, recovering for a second
session from the losses, with London's FTSE 100 .FTSE up 1.2%,
Germany's DAX .GDAXI gaining 0.4% and France's CAC 40 .FCHI
rising 0.6%.
IHS Markit's survey released earlier showed euro zone
business growth ground to a halt in September, as fresh curbs to
quell a resurgence in COVID-19 infections slammed the services
industry into reverse, more than offsetting the strongest
manufacturing growth in two years. However, investors counted on further stimulus from central
banks and governments to battle the economic fallout of the
health crisis.
"We expect data to further deteriorate given the new
restriction measures put in place... which will impact
employment data and keep pressure on both European governments
and the ECB in the coming months," wrote Olivier Konzeoue, FX
Sales trader at Saxo Markets.
UK markets outperformed, with British finance minister Rishi
Sunak looking to set out the future of the coronavirus job
support package on Thursday, just weeks before the 52 billion
pound ($66 billion) programme is set to expire. Travel stocks .SXTP rebounded after a four-day run of
losses, with Germany's Lufthansa LHAG.DE up 1.6% after news
the airline was planning to make rapid COVID-19 antigen tests
available to passengers in October. Adidas ADSGn.DE jumped 4.4%, while Puma PUMG.DE and JD
Sports JD.L gained about 4% each after U.S. sportswear maker
Nike NKE.N reported strong earnings and forecast
better-than-expected sales for 2020.
Osram Licht OSRn.DE surged 14.1% after Austrian sensor
maker ams AMS.VI said it had signed a so-called domination and
profit and loss transfer agreement as a key step towards closing
its 4.6 billion euro ($5.4 billion) takeover of the German firm.
Danish pharmaceutical company Genmab GMAB.CO fell 5.2%
after it said it was locked in a legal battle with its partner
Johnson & Johnson JNJ.N over royalty payments for its key
cancer drug. Swiss drugmaker Roche ROG.S slipped nearly 2% as its
experimental Alzheimer's drug failed to slow cognitive and
functional decline in a trial.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2024 - Fusion Media Limited. All Rights Reserved.